Asthma Control Study 2011

October 24, 2011 updated by: AstraZeneca
Asthma control study 2011

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

1524

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Hungary
      • Adásztevel, Hungary
        • Research Site
      • Ajka, Hungary
        • Research Site
      • Albertirsa, Hungary
        • Research Site
      • Baja, Hungary
        • Research Site
      • Balatonendréd, Hungary
        • Research Site
      • Budajenő, Hungary
        • Research Site
      • Budakeszi, Hungary
        • Research Site
      • Budapest, Hungary
        • Research Site
      • Békés, Hungary
        • Research Site
      • Békéscsaba, Hungary
        • Research Site
      • Celldömölk, Hungary
        • Research Site
      • Dabas, Hungary
        • Research Site
      • Debrecen, Hungary
        • Research Site
      • Dombóvár, Hungary
        • Research Site
      • Dunaújváros, Hungary
        • Research Site
      • Edelény, Hungary
        • Research Site
      • Eger, Hungary
        • Research Site
      • Encs, Hungary
        • Research Site
      • Esztergom, Hungary
        • Research Site
      • Gyula, Hungary
        • Research Site
      • Gyöngyös, Hungary
        • Research Site
      • Győr, Hungary
        • Research Site
      • Hatvan, Hungary
        • Research Site
      • Hódmezővásárhely, Hungary
        • Research Site
      • Kaposvár, Hungary
        • Research Site
      • Kecskemét, Hungary
        • Research Site
      • Kisbér, Hungary
        • Research Site
      • Kiskunfélegyháza, Hungary
        • Research Site
      • Kiskunhalas, Hungary
        • Research Site
      • Komárom, Hungary
        • Research Site
      • Körmend, Hungary
        • Research Site
      • Lenti, Hungary
        • Research Site
      • Miskolc, Hungary
        • Research Site
      • Monor, Hungary
        • Research Site
      • Mosdós, Hungary
        • Research Site
      • Mátraháza, Hungary
        • Research Site
      • Mór, Hungary
        • Research Site
      • Nagykanizsa, Hungary
        • Research Site
      • Nyíregyháza, Hungary
        • Research Site
      • Paks, Hungary
        • Research Site
      • Pécs, Hungary
        • Research Site
      • Sopron, Hungary
        • Research Site
      • Szarvas, Hungary
        • Research Site
      • Szeged, Hungary
        • Research Site
      • Szombathely, Hungary
        • Research Site
      • Székesfehérvár, Hungary
        • Research Site
      • Tata, Hungary
        • Research Site
      • Tatabánya, Hungary
        • Research Site
      • Tiszaújváros, Hungary
        • Research Site
      • Törökbálint, Hungary
        • Research Site
      • Törökszentmiklós, Hungary
        • Research Site
      • Veszprém, Hungary
        • Research Site
      • Zalaegerszeg, Hungary
        • Research Site

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Asthmatic patients above 18 y

Description

Inclusion Criteria:

  • Asthmatic patients above 18 y

Exclusion Criteria:

  • COPD
  • pulmonary cancer
  • pulmonary tuberculosis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Asthma control level
Time Frame: 2 times
2 times

Secondary Outcome Measures

Outcome Measure
Time Frame
Routine Therapeutical habits in control maintenance
Time Frame: 2 time
2 time

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

AstraZeneca

Investigators

  • Principal Investigator: György Losonczy, MD PHD, Semmelweis University Budapest Pulmonology Clinic

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2011

Primary Completion (Actual)

October 1, 2011

Study Completion (Actual)

October 1, 2011

Study Registration Dates

First Submitted

February 16, 2011

First Submitted That Met QC Criteria

February 16, 2011

First Posted (Estimate)

February 18, 2011

Study Record Updates

Last Update Posted (Estimate)

October 25, 2011

Last Update Submitted That Met QC Criteria

October 24, 2011

Last Verified

October 1, 2011

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • NIS-RHU-XXX-2011/1

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Asthma Control Level

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ukraine

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe